1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144 (8):1941-1953. doi:10.1002/ijc.31937
2. Nixon IJ, Whitcher MM, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I (2012) The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid 22 (9):884-889. doi:10.1089/thy.2011.0535
3. Vuong HG, Duong UNP, Pham TQ, Tran HM, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T (2018) Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis. World J Surg 42 (4):1005-1017. doi:10.1007/s00268-017-4206-1
4. Vuong HG, Altibi AM, Duong UN, Ngo HT, Pham TQ, Tran HM, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T (2017) Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis. Tumour Biol 39 (10):1010428317713913. doi:10.1177/1010428317713913
5. Gandolfi G, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A, Sancisi V (2015) TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur J Endocrinol 172 (4):403-413. doi:10.1530/eje-14-0837
6. Vuong HG, Odate T, Ngo HTT, Pham TQ, Tran TTK, Mochizuki K, Nakazawa T, Katoh R, Kondo T (2018) Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis. Endocr Relat Cancer 25 (6):633-641. doi:10.1530/erc-18-0056
7. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW (2007) Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110 (7):1451-1456. doi:10.1002/cncr.22956
8. Haq M, Harmer C (2005) Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 63 (1):87-93. doi:10.1111/j.1365-2265.2005.02304.x
9. Shaha AR, Shah JP, Loree TR (1996) Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172 (6):692-694. doi:10.1016/s0002-9610(96)00310-8
10. Chow SM, Law SC, Au SK, Leung TW, Chan PT, Mendenhall WM, Lau WH (2002) Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck 24 (7):670-677. doi:10.1002/hed.10080
11. Pacini F, Castagna MG, Cipri C, Schlumberger M (2010) Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) 22 (6):475-485. doi:10.1016/j.clon.2010.05.002
12. Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas ME (2017) Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid 27 (5):672-681. doi:10.1089/thy.2016.0395
13. Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA (2016) Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest 126 (3):1052-1066. doi:10.1172/jci85271
14. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K (2012) Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid 22 (8):798-804. doi:10.1089/thy.2012.0051
15. Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98 (4):712-719. doi:10.1002/cncr.11581
16. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K, Ito K (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21 (7):751-757. doi:10.1089/thy.2010.0353
17. Sugitani I, Fujimoto Y, Yamamoto N (2008) Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143 (1):35-42. doi:10.1016/j.surg.2007.06.011
18. Pazaitou-Panayiotou K, Chrisoulidou A, Mandanas S, Tziomalos K, Doumala E, Patakiouta F (2014) Predictive factors that influence the course of medullary thyroid carcinoma. Int J Clin Oncol 19 (3):445-451. doi:10.1007/s10147-013-0588-8
19. Besic N, Gazic B (2013) Sites of metastases of anaplastic thyroid carcinoma: autopsy findings in 45 cases from a single institution. Thyroid 23 (6):709-713. doi:10.1089/thy.2012.0252
20. Hugen N, Sloot YJE, Netea-Maier RT, van de Water C, Smit JWA, Nagtegaal ID, van Engen-van Grunsven ICH (2020) Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry. J Clin Endocrinol Metab 105 (3):e299-306. doi:10.1210/clinem/dgz078
21. Machens A, Dralle H (2012) Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab 97 (12):4375-4382. doi:10.1210/jc.2012-1257
22. Wang LY, Palmer FL, Nixon IJ, Thomas D, Patel SG, Shaha AR, Shah JP, Tuttle RM, Ganly I (2014) Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. Thyroid 24 (11):1594-1599. doi:10.1089/thy.2014.0173
23. Jung CK, Jung SH, Jeon S, Jeong YM, Kim Y, Lee S, Bae JS, Chung YJ (2020) Risk Stratification Using a Novel Genetic Classifier Including PLEKHS1 Promoter Mutations for Differentiated Thyroid Cancer with Distant Metastasis. Thyroid 30 (11):1589-1600. doi:10.1089/thy.2019.0459
24. Braun AD, Mengoni M, Bonifatius S, Tüting T, Gaffal E (2020) Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice. J Invest Dermatol 140 (7):1410-1417.e1412. doi:10.1016/j.jid.2019.12.020
25. Vuong HG, Altibi AMA, Duong UNP, Hassell L (2017) Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis. Clin Endocrinol (Oxf) 87 (5):411-417. doi:10.1111/cen.13413
26. Vuong HG, Duong UN, Altibi AM, Ngo HT, Pham TQ, Tran HM, Gandolfi G, Hassell L (2017) A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocr Connect 6 (3):R8-r17. doi:10.1530/ec-17-0010
27. Xu B, Ghossein R (2016) Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma. Endocr Pathol 27 (3):205-212. doi:10.1007/s12022-016-9445-4
28. Benbassat CA, Mechlis-Frish S, Hirsch D (2006) Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg 30 (6):1088-1095. doi:10.1007/s00268-005-0472-4